Shares of Vivos Inc. (OTCMKTS:RDGL - Get Free Report) shot up 3.6% during trading on Tuesday . The stock traded as high as $0.15 and last traded at $0.14. 549,728 shares traded hands during trading, a decline of 44% from the average session volume of 981,219 shares. The stock had previously closed at $0.13.
Vivos Stock Down 3.2%
The firm has a market capitalization of $59.64 million, a price-to-earnings ratio of -13.15 and a beta of 1.10. The firm's 50 day moving average is $0.12 and its 200 day moving average is $0.12.
Vivos Company Profile
(
Get Free Report)
Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.
Featured Articles
Before you consider Vivos, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vivos wasn't on the list.
While Vivos currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
